283 related articles for article (PubMed ID: 18635257)
1. COMET's path, and the new biologicals in rheumatoid arthritis.
Kremer JM
Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
[No Abstract] [Full Text] [Related]
2. [Therapy of rheumatoid arthritis with etanercept].
Lamprecht P; Nitschmann S
Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
[No Abstract] [Full Text] [Related]
3. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
[TBL] [Abstract][Full Text] [Related]
4. [Biologic therapy with anti-TNFα in rheumathoid arthritis].
Ferraccioli G
Reumatismo; 2005; 57(4 Suppl):17-21. PubMed ID: 16385351
[TBL] [Abstract][Full Text] [Related]
5. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al.
Yazici Y; Yazici H
Arthritis Rheum; 2006 Sep; 54(9):3061-2. PubMed ID: 16948140
[No Abstract] [Full Text] [Related]
6. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
Fath R
MMW Fortschr Med; 2004 Sep; 146(37):4-5. PubMed ID: 15887690
[No Abstract] [Full Text] [Related]
7. COMET results are not stellar.
James M; Cleland L
Lancet; 2008 Nov; 372(9652):1807-8; author reply 1808. PubMed ID: 19027480
[No Abstract] [Full Text] [Related]
8. Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
van der Heijde D; Klareskog L
Arthritis Rheum; 2007 Mar; 56(3):1031-2. PubMed ID: 17328083
[No Abstract] [Full Text] [Related]
9. Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et al.
Seitz M; Villiger PM
Arthritis Rheum; 2003 Mar; 48(3):863. PubMed ID: 12632454
[No Abstract] [Full Text] [Related]
10. A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study.
Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T;
Ann Rheum Dis; 2013 Feb; 72(2):310-2. PubMed ID: 22975754
[No Abstract] [Full Text] [Related]
11. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
Emery P; Breedveld FC; Hall S; Durez P; Chang DJ; Robertson D; Singh A; Pedersen RD; Koenig AS; Freundlich B
Lancet; 2008 Aug; 372(9636):375-82. PubMed ID: 18635256
[TBL] [Abstract][Full Text] [Related]
12. New drugs for rheumatoid arthritis.
Messori A; Santarlasci B; Vaiani M
N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
[No Abstract] [Full Text] [Related]
13. Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate.
Kavanaugh A; Klareskog L; van der Heijde D; Li J; Freundlich B; Hooper M
Ann Rheum Dis; 2008 Oct; 67(10):1444-7. PubMed ID: 18535115
[TBL] [Abstract][Full Text] [Related]
14. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.
Emery P; Breedveld F; van der Heijde D; Ferraccioli G; Dougados M; Robertson D; Pedersen R; Koenig AS; Freundlich B;
Arthritis Rheum; 2010 Mar; 62(3):674-82. PubMed ID: 20187135
[TBL] [Abstract][Full Text] [Related]
15. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
[No Abstract] [Full Text] [Related]
16. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
Gaudin P
Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
[No Abstract] [Full Text] [Related]
17. [Biologicals in the treatment of rheumatic diseases].
Scherer HU; Burmester GR
Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
[No Abstract] [Full Text] [Related]
18. Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
Cutolo M
Clin Exp Rheumatol; 2001; 19(6):626-7. PubMed ID: 11791631
[No Abstract] [Full Text] [Related]
19. Etanercept in rheumatoid arthritis.
Ferraccioli GF; Di Poi E
N Engl J Med; 1999 Jun; 340(25):2000-1. PubMed ID: 10383275
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis.
Yazici Y; Yazici H
Clin Exp Rheumatol; 2008; 26(3):449-52. PubMed ID: 18578967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
